Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with Para A of Part A of Schedule III to the said Regulations, we hereby inform that Ms. Nidhi Ajudia (DIN: 08607725) Non- Executive and Independent Director of the Company has, vide their letters dated 10th February, 2021, tendered her resignation as Director of the Company from the said position.
10-02-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We herewith enclose a Certificate dated 5th January, 2021 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 31st December, 2020 received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent of our company. Thanking you,
06-01-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dimpy JoshiDesignation :- Company Secretary and Compliance Officer
06-01-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Shareholding for the Period Ended December 31, 2020

 Indo Us Bio-Tech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
05-01-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo-US Agriseeds Pvt Ltd
26-11-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo Us Agriseeds Pvr Ltd
26-11-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Results- Financial Results For Sept 30, 2020

 With reference to captioned subject and pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Unaudited Financial Results, Provisional Balance Sheet, Profit and Loss Account and Cash Flow Statement for the Quarter and Half year ended on 30th September, 2020, along with Limited Review Report for the half year ended on 30th September, 2020. Kindly take the same on your record and oblige us.
13-11-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Outcome Of The Meeting Of The Board Of Directors Of The Company

 With regard to the captioned subject and in compliance with the Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, This is to inform you under Regulation 30 and any other Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company was held on Friday, 13th Day of November, 2020 and said Board meeting commenced at 11.00 a.m. and concluded at 11:30 a.m. have inter- alia considered and approved; 1. The Un-audited financial results, Provisional Balance Sheet, Profit and Loss Account and Cash Flow Statement along with limited review report of the Company for the quarter and half year ended on 30th September, 2020. These are also being made available on the website of the Company at www.indousagriseeds.com. Please take the same on your records
13-11-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On November 13, 2020

 Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve below: 1. To consider and approve the Unaudited Financial Results for the Quarter and Half Year ended on 30th September, 2020. 2. Any other matter with the permission of the Chair. We request you to kindly take note of the same and oblige. Thanking You,
07-11-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that the Company has appointed M/s. Gautam N Associates (FRN: 103117W), Chartered Accountants, Aurangabad as the Statutory Auditors of the Company u/s 139 of the Companies Act, 2013 for the financial year 2020-21.
16-10-2020
Next Page
Close

Let's Open Free Demat Account